Cohance Lifesciences Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health68/100
Valuation
20/100 · PB 18.0659
Technical
Avoid
1M -11.163%
6M -26.637%
1Y -28.147%
Confidence100%
Low leverage (D/E)Healthy profit margins
Promoter pledge present